Message-ID: <27625975.1075862158112.JavaMail.evans@thyme>
Date: Fri, 23 Nov 2001 13:01:42 -0800 (PST)
From: members@thestreet.com
To: f..keavey@enron.com
Subject: RealMoney Weekend: Market Says 'Me, Too' to Black Friday Buying
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-From: "RealMoney.com" <members@thestreet.com>@ENRON
X-To: Keavey, Peter F. </O=ENRON/OU=NA/CN=RECIPIENTS/CN=PKEAVEY>
X-cc: 
X-bcc: 
X-Folder: \PKEAVEY (Non-Privileged)\Keavey, Peter F.\Deleted Items
X-Origin: Keavey-P
X-FileName: PKEAVEY (Non-Privileged).pst

RealMoney.com's WEEKEND BULLETIN

November 23, 2001

http://www.realmoney.com
____________________________________
Companies in Today's Bulletin:

Conseco (CNC:NYSE)
Corning (GLW:NYSE)
Eli Lilly (LLY:NYSE)
Ivax (IVX:NYSE)
____________________________________
The Market Story: Market Says 'Me, Too' to Black Friday Buying

Retailers tack on some gains as the Dow finishes the week with a
triple-digit gain.

http://www.thestreet.com/markets/marketstory/10004368.html
____________________________________
Christopher Edmonds: From Russia Without Love -- No Respect for OPEC

With market share falling and Russia refusing to play, any cartel
production cuts will be leaky.

http://www.thestreet.com/comment/chrisedmonds/10004385.html
____________________________________
TSC Technical Forum: Nasdaq's Candle Lights the Way to an Up Day

Plus charts on Public Storage, Snap-On, Corning, Guidant and more.

http://www.thestreet.com/p/rmoney/techforumrm/10004365.html
____________________________________
Adam Feuerstein: Ivax Says It Has Approval to Sell Generic Glucophage

Bristol-Myers is trying to save its blockbuster patent by going to
Congress.

http://www.thestreet.com/tech/adamfeuerstein/10004386.html
____________________________________
Detox: Cash Concerns Cramp Conseco

Loan growth won't be sufficient to fund the debt-heavy company's needs.

http://www.thestreet.com/markets/detox/10004311.html
____________________________________
Biotech/Pharmaceuticals: Trumping a Rival, Lilly Says Its Sepsis Drug
Has FDA Approval

The announcement comes just hours after Chiron said its sepsis drug
missed goals.

http://www.thestreet.com/stocks/biotech/10004339.html
____________________________________
Rebecca Byrne: World Trade Center Leases Still Standing

Silverstein Properties says no rent is due, but the company's actions
have some worried.

http://www.thestreet.com/markets/rebeccabyrne/10004381.html
____________________________________
Eric Gillin: Here We Come A-Discounting

Retailers go for the green by offering plenty of holiday incentives.

http://www.thestreet.com/markets/ericgillin/10004308.html
____________________________________
Kristen French: Balance Sheets Headed for Holiday Wringer

Look for an abundance of write-offs this earnings season.

http://www.thestreet.com/markets/kristenfrench/10004317.html
____________________________________
Numbers Game: Giving Thanks and Looking Ahead

If you've weathered the rough times and stayed in the game, it's a good
time to think about 2002.

http://www.thestreet.com/comment/numbersgame/10004272.html
____________________________________
Mutual Fund Monday: Ten Things You Should Do Before You Invest

Get your financial life in order, for crying out loud.

http://www.thestreet.com/funds/mutualfundmonday/10003073.html
______________________________________________________________________
November 26

James J. Cramer will host TheStreet.com's radio show "RealMoney with
Jim Cramer." The show airs daily from 3-4 p.m. EDT. Got a question for
Jim Cramer? Call 1-800-862-8686.
______________________________________________________________________
Advertisement

Tech Edge

                     ** The Tech Edge **
Own tech stocks? Looking to invest in tech stocks? Waiting for a tech
turnaround? Get The Tech Edge by Scott Moritz and make critical
decisions with confidence!
Click here to sign up today for your FREE two-week trial!
http://sub.thestreet.com/c/go/XTEK/RM1A-xtekTA1?s=S961&D=XTEK
______________________________________________________________________
If you would like to be removed from our bulletin mailing list, or
would like to select which of our bulletins you receive, please go to
the following URL:

http://www.thestreet.com/p/upc/bulletin.jhtml
____________________________________________________________________

Copyright Notice

Except for making one printed copy of this or any other materials,
files or documents available from, accessible through or published by
TheStreet.com Inc. for your personal use (or downloading for the same
limited purpose), these may not be reproduced, republished, broadcast
or otherwise distributed without prior written permission of
TheStreet.com Inc.

For bulk reprints of any article, please contact Brad Glouner at
Reprint Management Services, at (717) 399-1900 ext. 130, or via email
at bglouner@rmsreprints.com.
____________________________________________________________________
For general comments, questions or suggestions, please send an email to
feedback@realmoney.com.

For letters about our editorial content intended for publication,
please send an email to letters@realmoney.com. Remember to include your
full name and city.

If you have a question regarding your account, please contact us at
members@realmoney.com.
____________________________________________________________________

For TheStreet.com's privacy policy, please click here:
http://www.thestreet.com/tsc/about/privacy.html.

Email delivery and ad services are provided by DoubleClick's DARTmail.
Click here for important privacy information:
http://www.privacychoices.org/
____________________________________________________________________
Copyright 2000 TheStreet.com, Inc. All rights reserved.























